Everence Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,280	Closed	-$364K	–	960
2024 Q3	$364K	Hold	13,280	–	–	0.02%	522
2024 Q2	$260	Hold	13,280	–	–	0.02%	589
2024 Q1	$283	Hold	13,280	–	–	0.02%	584
2023 Q4	$254K	Hold	13,280	–	–	0.02%	614
2023 Q3	$213	Hold	13,280	–	–	0.02%	649
2023 Q2	$293K	Hold	13,280	–	–	0.02%	532
2023 Q1	$308	Hold	13,280	–	–	0.03%	531
2022 Q4	$193	Hold	13,280	–	–	0.02%	699
2022 Q3	$253K	Hold	13,280	–	–	0.02%	575
2022 Q2	$241K	Hold	13,280	–	–	0.02%	586
2022 Q1	$335K	Hold	13,280	–	–	0.03%	529
2021 Q4	$367K	Hold	13,280	–	–	0.03%	526
2021 Q3	$429K	Hold	13,280	–	–	0.04%	445
2021 Q2	$406K	Hold	13,280	–	–	0.03%	460
2021 Q1	$404K	Hold	13,280	–	–	0.04%	442
2020 Q4	$263K	Hold	13,280	–	–	0.03%	560
2020 Q3	$173K	Sell	13,280 -200	-1%	-$2.61K	0.02%	605
2020 Q2	$196K	Hold	13,480	–	–	0.02%	583
2020 Q1	$193K	Hold	13,480	–	–	0.03%	523
2019 Q4	$367K	Hold	13,480	–	–	0.05%	406
2019 Q3	$386K	Hold	13,480	–	–	0.06%	341
2019 Q2	$374K	Buy	+13,480	New	+$374K	0.06%	350